Generated Narrative: StructureDefinition HIVCPrEPvisit Profiles: CRMI Shareable StructureDefinition, CRMI Publishable StructureDefinition Name Flags Card. Type Description & Constraints HIVCPrEPvisit 0..* Base HIV.C PrEP visit Instances of this logical model can be the target of a Reference #xD; reasonForPrepVisit 1..1 Coding Reason for PrEP visit Binding: Reason for PrEP visit ValueSet (required) #xD; threeMonthPrepVisit 0..1 boolean 3-month PrEP visit #xD; contactWithAndSuspectedExposureToHiv 0..1 boolean Contact with and (suspected) exposure to HIV #xD; dateTimeOfSuspectedExposureToHiv 0..1 dateTime Date/time of suspected exposure to HIV #xD; currentlyOnPrep 0..1 boolean Currently on PrEP #xD; prepDosingType 0..1 Coding PrEP dosing type Binding: PrEP dosing type ValueSet (required) #xD; otherPrepDosingTypeSpecify 0..1 string Other PrEP dosing type (specify) #xD; usedEventDrivenPrepForAtRiskExposuresOverThePast3Months 0..1 boolean Used event-driven PrEP for at risk exposures over the past 3 months #xD; currentPrepRegimen 0..1 Coding Current PrEP regimen Binding: Current PrEP regimen ValueSet (required) #xD; experienceWithPrep 0..1 Coding Experience with PrEP Binding: Experience with PrEP ValueSet (required) #xD; prepStartDate 0..1 date PrEP start date #xD; stoppedPrep 0..1 boolean Stopped PrEP #xD; datePrepStopped 0..1 date Date PrEP stopped #xD; pepHistory 0..1 Coding PEP history Binding: PEP history ValueSet (required) #xD; datesOfPastPepUse 0..1 date Date(s) of past PEP use #xD; dateClientCompletesPepCourse 0..1 date Date client completes PEP course #xD; signsOfSubstantialRiskOfHivInfection 1..* Coding Signs of substantial risk of HIV infection Binding: Signs of substantial risk of HIV infection ValueSet (required) #xD; pregnancyIntentionInSerodiscordantPartnerships 1..1 Coding Pregnancy intention in serodiscordant partnerships Binding: Pregnancy intention in serodiscordant partnerships ValueSet (required) #xD; acuteHivInfectionSymptoms 0..* Coding Acute HIV infection symptoms Binding: Acute HIV infection symptoms ValueSet (required) #xD; sexPartnerHivTreatmentStatus 0..* Coding Sex partner's HIV treatment status Binding: Sex partner's HIV treatment status ValueSet (required) #xD; suitableForPrep 0..1 boolean Suitable for PrEP #xD; offeredPrep 0..1 boolean Offered PrEP #xD; screeningsAndDiagnosticsForPrepUsers 0..* Coding Screenings and diagnostics for PrEP users Binding: Screenings and diagnostics for PrEP users ValueSet (required) #xD; serumCreatinineTestDate 0..1 date Serum creatinine test date #xD; serumCreatinineTestResult 0..1 integer Serum creatinine test result #xD; dateMedicationsDispensed 0..1 date Date medications dispensed #xD; dateMedicationsPrescribed 0..1 date Date medications prescribed #xD; medicationsPrescribed 0..1 Coding Medications prescribed Binding: Medications prescribed ValueSet (required) #xD; otherMedicationsPrescribed 0..1 string Other (specify) #xD; prepProductPrescribed 0..1 Coding PrEP product prescribed Binding: PrEP product prescribed ValueSet (required) #xD; otherPrepProductPrescribed 0..1 string Other (specify) #xD; datePrepPrescribed 0..1 date Date PrEP prescribed #xD; datePrepDispensed 0..1 date Date PrEP dispensed #xD; volumeOfPrepProductPrescribedDispensed 0..1 integer Volume of PrEP product prescribed/dispensed #xD; datePepPrescribed 0..1 date Date PEP prescribed #xD; datePepCourseCompletion 0..1 date Date PEP course completion #xD; preferredPepBackboneRegimen 0..1 Coding Preferred PEP backbone regimen Binding: Preferred PEP backbone regimen ValueSet (required) #xD; alternativePepBackboneRegimen 0..* Coding Alternative PEP backbone regimen Binding: Alternative PEP backbone regimen ValueSet (required) #xD; preferredThirdPepDrug 0..* Coding Preferred third PEP drug Binding: Preferred third PEP drug ValueSet (required) #xD; alternativeThirdPepDrug 0..* Coding Alternative third PEP drug Binding: Alternative third PEP drug ValueSet (required) #xD; estimatedCreatinineClearance 0..1 integer Estimated creatinine clearance #xD; <a href="StructureDefinition-HIVCPrEPvisit-definitions.html#HIVCPrEPvisit.sexFactorForEstimatingCreatinineClearance" title="Value used for gender for calculating creatinine clearance if required. For transgender populations, the sex at birth is used in the Cockcroft-Gault equation if the person is not using hormone therapy; among transgender populations using hormone therapy for more than three months, the current gender can be used.">sexFactorForEstimatingCreatinineClearance 0..1 Coding Sex factor for estimating creatinine clearance Binding: Sex factor for estimating creatinine clearance ValueSet (required) #xD; <a href="StructureDefinition-HIVCPrEPvisit-definitions.html#HIVCPrEPvisit.estimatedCreatinineClearanceCockcroftGaultEquation" title="If the laboratory does not have the capacity to estimate creatinine clearance, the provider can use the Cockcroft–Gault equation to calculate estimated creatinine clearance based on measured serum creatinine, the client’s sex at birth, age and estimated lean body weight.">estimatedCreatinineClearanceCockcroftGaultEquation 0..1 integer Estimated creatinine clearance (Cockcroft–Gault equation) #xD; dateOfSampleCollection 0..1 dateTime Date of sample collection #xD; contraindicationsToPrepUsage 0..* Coding Contraindications to PrEP usage Binding: Contraindications to PrEP usage ValueSet (required) #xD; otherAllergyOrContraindicationToAMedicineInThePrepRegimenSpecify 0..1 string Other allergy or contraindication to a medicine in the PrEP regimen (specify) #xD; prescribedPrepAtInitialVisit 0..1 boolean Prescribed PrEP at initial visit #xD; numberOfDaysPrescribed 0..1 integer Number of days prescribed #xD; prepRegimenPrescribed 0..* Coding PrEP regimen prescribed Binding: PrEP regimen prescribed ValueSet (required) #xD; adherenceCounsellingProvided 0..1 boolean Adherence counselling provided #xD; dateTimeOfFollowUpAppointment 0..1 dateTime Date/time of follow-up appointment #xD; typeOfFollowUpAppointment 0..1 Coding Type of follow-up appointment Binding: Type of follow-up appointment ValueSet (required) #xD; otherTypeOfFollowUpAppointment 0..1 string Other (specify) #xD; linkedToEnrolmentInCareAndArtInitiation 0..1 boolean Linked to enrolment in care and ART initiation #xD; preventionServicesOfferedAndReferrals 0..* Coding Prevention services offered and referrals Binding: Prevention services offered and referrals ValueSet (required) #xD; dateProvidedCondoms 0..1 date Date provided condoms #xD; condomsDistributed 0..1 integer Condoms distributed #xD; condomType 0..1 Coding Condom type Binding: Condom type ValueSet (required) #xD; hivSelfTestKitsAccepted 0..1 boolean HIV self-test kits accepted #xD; numberOfHivSelfTestKitsDistributed 0..1 integer Number of HIV self-test kits distributed #xD; hivSelfTestDistributedForUseBy 0..1 Coding HIV self-test distributed for use by Binding: HIV self-test distributed for use by ValueSet (required) #xD; sexualAndReproductiveHealthIntegratedServices 0..* Coding Sexual and reproductive health integrated services Binding: Sexual and reproductive health integrated services ValueSet (required) #xD; offerOtherClinicalServices 0..* Coding Offer other clinical services Binding: Offer other clinical services ValueSet (required) #xD; otherSupportServices 0..* Coding Other support services Binding: Other support services ValueSet (required) #xD; Documentation for this format
This tab describes the data that may be collected during the pre-exposure prophylaxis (PrEP) or post-exposure prophylaxis (PEP) workflow (HIV.C)
Client's reason for the prevention visit
Client is visiting for the recommended 3-month pre-exposure prophylaxis (PrEP) visit
Contact with and (suspected) exposure to HIV
The client had suspected or known exposure to HIV
When the suspect exposure to HIV took place
The client is currently taking PrEP. Oral pre-exposure prophylaxis (PrEP) of HIV is the use of ARV drugs by people who are not infected with HIV to block the acquisition of HIV.
Way in which pre-exposure prophylaxis (PrEP) is taken (daily or event-driven)
Used event-driven PrEP for at risk exposures over the past 3 months
Client reports taking ED-PrEP for at risk exposures over a 3-month period
HIV pre-exposure prophylaxis (PrEP) regimen
The date on which the client started or restarted pre-exposure prophylaxis (PrEP)
Client stopped taking pre-exposure prophylaxis (PrEP)
Date client stopped taking pre-exposure prophylaxis (PrEP)
The client's history in taking post-exposure prophylaxis (PEP) for HIV prevention
Dates when the client previously used post-exposure prophylaxis (PEP)
Signs of substantial risk of HIV infection
Signs the client is at a substantial risk of HIV infection
Pregnancy intention in serodiscordant partnerships
Client's intention or desire in the next year to either become pregnant or prevent a future pregnancy (in serodiscordant partnerships)
Symptoms that could suggest an acute HIV infection
Treatment adherence of client's sex partner for partners that are HIV-positive
After being evaluated as suitable for PrEP, the client was offered PrEP
Screenings and diagnostics for PrEP users
Listing of tests for clients on or starting pre-exposure prophylaxis (PrEP) that may be recommended or should be considered
Test serum creatinine to identify pre-existing renal disease (estimated creatinine clearance less than 60 ml/min)
Test serum creatinine to identify pre-existing renal disease (estimated creatinine clearance less than 60 ml/min).
Date the client was dispensed medications
Date the client was prescribed medications
Client was prescribed other medications (specify)
PrEP product that the client was prescribed
Client was prescribed other PrEP product (specify)
Date client was prescribed PrEP, including initial prescription and repeats
Volume of PrEP product prescribed/dispensed
Volume of PrEP product the client was prescribed or dispensed (for example, number of pills, number of devices)
Estimated creatinine clearance of the client returned from lab in mL/min
Sex factor for estimating creatinine clearance
Value used for gender for calculating creatinine clearance if required. For transgender populations, the sex at birth is used in the Cockcroft-Gault equation if the person is not using hormone therapy; among transgender populations using hormone therapy for more than three months, the current gender can be used.
Estimated creatinine clearance (Cockcroft–Gault equation)
If the laboratory does not have the capacity to estimate creatinine clearance, the provider can use the Cockcroft–Gault equation to calculate estimated creatinine clearance based on measured serum creatinine, the client’s sex at birth, age and estimated lean body weight.
Listing of contraindications to pre-exposure prophylaxis (PrEP)
Other allergy or contraindication to a medicine in the PrEP regimen (specify)
Client has another allergy or contraindication to a medicine in the pre-exposure prophylaxis (PrEP) regimen (specify)
Client was prescribed pre-exposure prophylaxis (PrEP) on a first visit
Days of medication client has been prescribed
HIV pre-exposure prophylaxis (PrEP) regimen prescribed
Whether adherence counselling was provided
Date the client is to return for monitoring, re-supply, or any other reason
Type of follow-up appointment for testing services
Other reason for the follow-up appointment (specify)
Linked to enrolment in care and ART initiation
Linkage made from HIV testing to enrolment in care following an HIV diagnosis
Prevention services offered and referrals
Number of condoms given to the client, if any were distributed
Whether any HIV self-test kits were given to the client
Number of HIV self-test kits distributed
Number of HIV self-test kits distributed to the client
Whom the client plans to give the HIV self-test kit (self, sexual partner, social contact, etc.)
Sexual and reproductive health integrated services
Offer or refer to sexual and reproductive health services
Other clinical services offered or referrals given to the client
Offer or refer for other support services